These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3594557)

  • 1. Blood velocity in the coronary artery circulation: relation to thromboxane A2 levels in coronary sinus in patients with angiographically normal coronary arteries.
    Di Donato M; Fantini F; Maioli M; Prisco D; Rogasi PG; Neri Serneri GG
    Cathet Cardiovasc Diagn; 1987; 13(3):162-6. PubMed ID: 3594557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal cardiocoronary thromboxane A2 production in patients with unstable angina.
    Neri Serneri GG; Gensini GF; Abbate R; Prisco D; Rogasi PG; Laureano R; Casolo GC; Fantini F; Di Donato M; Dabizzi RP
    Am Heart J; 1985 Apr; 109(4):732-8. PubMed ID: 3984828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thromboxane release in coronary artery disease: spontaneous versus pacing-induced angina.
    Mehta J; Mehta P; Feldman RL; Horalek C
    Am Heart J; 1984 Feb; 107(2):286-92. PubMed ID: 6695662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of thromboxane A2 in myocardial ischemia in patients with coronary artery disease.
    Tada M; Kuzuya T; Inoue M; Kodama K; Fukushima M; Abe H
    Adv Myocardiol; 1980; 2():397-405. PubMed ID: 7423053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of provocation on transcardiac thromboxane in patients with coronary artery disease.
    Hirsh PD; Firth BG; Campbell WB; Dehmer GJ; Willerson JT; Hillis LD
    Am J Cardiol; 1983 Mar; 51(5):727-33. PubMed ID: 6829431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thromboxane A2 as an enhancing factor of coronary vasospasticity in variant angina.
    Ohmori M; Kuzuya T; Kodama K; Nanto S; Kamada T; Tada M
    Jpn Circ J; 1987 May; 51(5):495-502. PubMed ID: 3626009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction in blood flow in normal and narrowed coronary arteries of dogs by leukotriene C4.
    Wargovich T; Mehta J; Nichols WW; Pepine CJ; Conti CR
    J Am Coll Cardiol; 1985 Nov; 6(5):1047-51. PubMed ID: 4045029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary vasoconstrictor response to cold pressor test in variant angina: lack of relation to intracoronary thromboxane concentrations.
    De Servi S; Ferrario M; Rondanelli R; Corsico G; Poma E; Ghio S; Mussini A; Angoli L; Bramucci E; Bré E
    Am Heart J; 1987 Sep; 114(3):511-5. PubMed ID: 3630891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thromboxane A2 in vasotonic angina pectoris: evidence from direct measurements and inhibitor trials.
    Robertson RM; Robertson D; Roberts LJ; Maas RL; FitzGerald GA; Friesinger GC; Oates JA
    N Engl J Med; 1981 Apr; 304(17):998-1003. PubMed ID: 7010173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of blood sampling site and technique on thromboxane concentrations in patients with ischemic heart disease.
    Hirsh PD; Firth BG; Campbell WB; Willerson JT; Hillis LD
    Am Heart J; 1982 Aug; 104(2 Pt 1):234-7. PubMed ID: 7102506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of nitroglycerin-induced coronary dilatation: lack of relation to intracoronary thromboxane concentrations.
    Rehr RB; Jackson JA; Winniford MD; Campbell WB; Hillis LD
    Am J Cardiol; 1984 Nov; 54(8):971-4. PubMed ID: 6437206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of thromboxane A2 blockade to prevent attacks of vasospastic angina.
    Chierchia S; de Caterina R; Crea F; Patrono C; Maseri A
    Circulation; 1982 Oct; 66(4):702-5. PubMed ID: 7116586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous alterations in coronary blood flow velocity before and after coronary angioplasty in patients with severe angina.
    Eichhorn EJ; Grayburn PA; Willard JE; Anderson HV; Bedotto JB; Carry M; Kahn JK; Willerson JT
    J Am Coll Cardiol; 1991 Jan; 17(1):43-52. PubMed ID: 1987239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal thromboxane, prostacyclin, and umbilical blood flow in humans.
    Ylikorkala O; Jouppila P; Kirkinen P; Viinikka L
    Obstet Gynecol; 1984 May; 63(5):677-80. PubMed ID: 6546976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular prostaglandin and thromboxane production in a canine model of myocardial ischemia.
    Schmitz JM; Apprill PG; Buja LM; Willerson JT; Campbell WB
    Circ Res; 1985 Aug; 57(2):223-31. PubMed ID: 3926340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostacyclin and thromboxane A2 in preeclamptic umbilical circulation.
    Takagi S; Den K
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():619-21. PubMed ID: 2936183
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of atrial pacing on intracoronary thromboxane production in coronary artery disease.
    Martin JL; Wilson JR; Burch JW; Untereker WJ; Laskey W; Ferraro N; Hirshfeld JW
    J Am Coll Cardiol; 1983 May; 1(5):1194-200. PubMed ID: 6833660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of alpha 2-adrenoceptors in normal and atherosclerotic human coronary circulation.
    Indolfi C; Piscione F; Villari B; Russolillo E; Rendina V; Golino P; Condorelli M; Chiariello M
    Circulation; 1992 Oct; 86(4):1116-24. PubMed ID: 1356656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between total cholesterol and thromboxane B2 levels in offspring of parents suffering from premature coronary artery disease.
    Mihai K; Petö J; Makáry A; Tímár S
    Agents Actions Suppl; 1992; 37():190-6. PubMed ID: 1632293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac-derived thromboxane A2. An initiating mediator of reperfusion injury?
    Byrne JG; Appleyard RF; Sun SC; Couper GS; Sloane JA; Laurence RG; Cohn LH
    J Thorac Cardiovasc Surg; 1993 Apr; 105(4):689-93. PubMed ID: 8469003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.